ACRV vs. BVS
Compare and contrast key facts about Acrivon Therapeutics Inc. Common Stock (ACRV) and Bioventus Inc. (BVS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ACRV or BVS.
Key characteristics
| ACRV | BVS | |
|---|---|---|
| YTD Return | 60.98% | 111.20% |
| 1Y Return | 52.60% | 186.49% |
| Sharpe Ratio | 0.51 | 2.81 |
| Sortino Ratio | 1.75 | 3.62 |
| Omega Ratio | 1.20 | 1.45 |
| Calmar Ratio | 0.66 | 2.45 |
| Martin Ratio | 2.34 | 18.04 |
| Ulcer Index | 23.90% | 10.87% |
| Daily Std Dev | 109.99% | 69.67% |
| Max Drawdown | -85.34% | -95.18% |
| Current Drawdown | -65.86% | -42.06% |
Fundamentals
| ACRV | BVS | |
|---|---|---|
| Market Cap | $259.86M | $773.95M |
| EPS | -$2.72 | -$0.61 |
| Total Revenue (TTM) | $1.88M | $555.06M |
| Gross Profit (TTM) | $1.31M | $365.95M |
| EBITDA (TTM) | -$59.59M | $104.14M |
Correlation
The correlation between ACRV and BVS is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ACRV vs. BVS - Performance Comparison
In the year-to-date period, ACRV achieves a 60.98% return, which is significantly lower than BVS's 111.20% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ACRV vs. BVS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Acrivon Therapeutics Inc. Common Stock (ACRV) and Bioventus Inc. (BVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ACRV vs. BVS - Dividend Comparison
Neither ACRV nor BVS has paid dividends to shareholders.
Drawdowns
ACRV vs. BVS - Drawdown Comparison
The maximum ACRV drawdown since its inception was -85.34%, smaller than the maximum BVS drawdown of -95.18%. Use the drawdown chart below to compare losses from any high point for ACRV and BVS. For additional features, visit the drawdowns tool.
Volatility
ACRV vs. BVS - Volatility Comparison
The current volatility for Acrivon Therapeutics Inc. Common Stock (ACRV) is 13.06%, while Bioventus Inc. (BVS) has a volatility of 21.98%. This indicates that ACRV experiences smaller price fluctuations and is considered to be less risky than BVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ACRV vs. BVS - Financials Comparison
This section allows you to compare key financial metrics between Acrivon Therapeutics Inc. Common Stock and Bioventus Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities